Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, October 29, 2015

Future of Quality and Outcomes Research in Stroke

All this blather and not one word on a strategy or planning on how to solve all the problems in stroke.
http://circoutcomes.ahajournals.org/content/8/6_suppl_3/S66.extract?etoc
  1. Lee H. Schwamm, MD
+ Author Affiliations
  1. From the Division of Cardiology, Geffen School of Medicine at UCLA, Los Angeles, CA (G.C.F.); Department of Medicine, University of Toronto, Toronto, Ontario, Canada (M.K.K.); and Department of Neurology, MGH Stroke Services, Fireman Vascular Center Massachusetts General Hospital, Harvard Medical School, Boston (L.H.S.).
  1. Correspondence to Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, 10833 LeConte Ave, Room 47-123 CHS, Los Angeles, CA 90095. E-mail gfonarow@mednet.ucla.edu
Stroke is a common and costly condition that affects 15 million people worldwide each year.1 Globally, stroke results in nearly 6 million deaths, and another 5 million people are permanently disabled by stroke each year. Stroke is the fourth leading cause of death, the second most common reason for hospitalization in older adults, and the most common cause of long-term disability in the United States.2 Although there have been important advances in stroke treatment and rehabilitation over the past few decades, stroke patients, care partners, and clinicians frequently still have too little information to determine which diagnostic tests, treatments, and strategies to apply and which to avoid in specific instances. There remain critical voids in knowledge about which approaches to stroke care are likely to produce optimal clinical outcomes for the greatest number of patients. In addition, despite well-developed repositories for the assessment of neurological quality of life and other patient-reported outcomes, the field of cerebrovascular disease has been slow to incorporate these measures into care planning and shared decision-making.3,4 Even when strong evidence exists, there are frequently gaps, variations, and disparities in how that evidence is applied in clinical practice. Challenges remain in accurately capturing and reporting quality and outcomes, including functional outcomes, that are properly risk adjusted. Quality and outcomes research in stroke is essential to bridging these substantial gaps in knowledge, better informing clinical decision making, and driving further improvements in stroke care and outcomes.

No comments:

Post a Comment